Skip to main content
SpringerLink
Log in

Inappropriate use of proton pump inhibitors

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Proton pump inhibitors (PPIs) are widely used expensive medications.

Aims

We performed a cross-sectional study to determine the extent and indication of PPI use in Irish acute medical wards.

Methods

Fifty-five medical charts were reviewed at the beginning and end of 1 month.

Results and conclusions

Thirty-three patients were prescribed PPIs; 26 prior to admission. The prescribing of PPIs was concordant with guideline recommendations in only 30% of cases. Two-thirds of PPI use was unlicensed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. HSE Primary Care Reimbursements Service. Statistical analysis of claims and payments 2006

  2. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary, March 2006, p 48

  3. Cunningham R, Dial S (2008) Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? J Hosp Infect 70:1–6

    Article  CAS  PubMed  Google Scholar 

  4. Laheij RJ, Sturkenboom MC, Hassing RJ, Dielman J, Stricker BH, Jansen JB (2004) Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 292:1955–1960

    Article  CAS  PubMed  Google Scholar 

  5. Yang YX, Lewis JD, Epstein S, Metz DC (2006) Long-term PPI therapy and risk of hip fracture. JAMA 296(24):2947–2953

    Article  CAS  PubMed  Google Scholar 

  6. Gilard M, Arnaud B, Cornily JC et al (2008) Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole Clopidogrel Aspirin) study. J Am Coll Cardiol 51:256–260

    Article  CAS  PubMed  Google Scholar 

  7. National Institute for Clinical Excellence (2000) Guidance on the use of proton pump inhibitors for dyspepsia. http://www.nice.org.uk

  8. Naunton M, Peterson GM, Bleasel MD (2000) Overuse of proton pump inhibitors. J Clin Pharm Ther 25:333–340

    Article  CAS  PubMed  Google Scholar 

  9. Sebastian SS, Kernan N, Qasim A, O’Morain CA, Buckley M (2003) Appropriateness of gastric antisecretory therapy in hospital practice. Ir J Med Sci 172(3):115–117

    Article  CAS  PubMed  Google Scholar 

  10. Van Vliet EP, Otten HJ, Rudolphus A et al (2008) Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. Eur J Gastroenterol Hepatol 20(7):608–612

    Article  PubMed  Google Scholar 

  11. Mat Saad AZ, Collins N, Lobo M, O’Connor HJ (2005) Proton pump inhibitors: a survey of prescribing in an Irish General hospital. Int J Clin Pract 59(1):31–34

    Article  CAS  PubMed  Google Scholar 

  12. Reilly JP (1999) Safety profile of the proton-pump inhibitors. Am J Health Syst Pharm 56(23 Suppl 4):S11–S17

    CAS  PubMed  Google Scholar 

  13. Laine L, Ahnen D, McClain C et al (2000) Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 14:651–668

    Article  CAS  PubMed  Google Scholar 

  14. Mouly S, Charlemagne A, Le Jeunne P, Fagnani F (2008) General practitioners’ management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study. Presse Med 37(10):1397–1406

    Article  PubMed  Google Scholar 

  15. Ryan G, Glynn L (2009) Overcoming barriers to rational prescribing. Forum J ICGP 26(2):40–42

    Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Murali Sayana, SpR, Department of Orthopaedic Surgery, Waterford Regional Hospital for the valuable suggestions in the writing of this paper.

Author information

Authors and Affiliations

  1. Department of Pharmacology and Therapeutics, St. James’s Hospital, Dublin 8, Ireland

    D. Molloy, A. Molloy, C. O’Loughlin, M. Falconer & M. Hennessy

Authors
  1. D. Molloy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Molloy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. O’Loughlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Falconer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Hennessy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Molloy.

Additional information

D. Molloy and A. Molloy contributed equally to the manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molloy, D., Molloy, A., O’Loughlin, C. et al. Inappropriate use of proton pump inhibitors. Ir J Med Sci 179, 73–75 (2010). https://doi.org/10.1007/s11845-009-0426-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-009-0426-1

Keywords

Search

Navigation